Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats - PubMed (original) (raw)

Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats

E Shinohara et al. Atherosclerosis. 1998 Feb.

Abstract

Troglitazone, a thiazolidinedione derivative, overcomes insulin resistance through promoting insulin receptor function. However, the effect of the resultant enhancement of insulin action on the regulation of cellular proliferation remains unknown. We investigated the effect of troglitazone on intimal proliferation after balloon injury in insulin-resistant Zucker fatty rats. Troglitazone markedly decreased blood glucose and triglyceride levels at the therapeutic dosage. The area of neointima significantly decreased in treated animals 2 weeks after operation, as compared with the untreated control animals (0.0526 +/- 0.0292 and 0.115 +/- 0.0354 mm2, respectively). The ratio of neointimal to medial area in treated rats (0.75 +/- 0.26) decreased by as much as 53% compared with untreated rats (1.40 +/- 0.05). We next examined DNA synthesis in cultured smooth muscle cells (SMCs) derived from non-insulin-resistant rats, to assess whether troglitazone suppresses the proliferation of vascular SMCs independent of metabolic effects. The result showed that troglitazone decreased [methyl-3H]thymidine incorporation into DNA. In conclusion, treatment with troglitazone in Zucker fatty rats resulted in a reduction in neointima formation after balloon injury, and also corrected hypertriglyceridemia and hyperglycemia. In addition, in vitro studies revealed that the anti-proliferative effect of troglitazone stems from its direct action on DNA synthesis rather than any accompanying metabolic changes. Therefore, troglitazone seems to be applicable in preventing atherosclerosis in patients with insulin resistance.

PubMed Disclaimer

Cited by

Efficacy of continuous positive airway pressure on subcutaneous adipose tissue in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials.
Liu Y, Li C, Wu C, Li P, Su Y, Chen Q. Liu Y, et al. Sleep Breath. 2021 Mar;25(1):1-8. doi: 10.1007/s11325-020-02078-1. Epub 2020 Apr 24. Sleep Breath. 2021. PMID: 32333260 Review.
Pioglitazone Attenuates Injury-Induced Neointima Formation in Mouse Femoral Artery Partially through the Activation of AMP-Activated Protein Kinase.
Osman I, Fairaq A, Segar L. Osman I, et al. Pharmacology. 2017;100(1-2):64-73. doi: 10.1159/000471769. Epub 2017 May 9. Pharmacology. 2017. PMID: 28482342 Free PMC article.
Pioglitazone Ameliorates Smooth Muscle Cell Proliferation in Cuff-Induced Neointimal Formation by Both Adiponectin-Dependent and -Independent Pathways.
Kubota T, Kubota N, Sato H, Inoue M, Kumagai H, Iwamura T, Takamoto I, Kobayashi T, Moroi M, Terauchi Y, Tobe K, Ueki K, Kadowaki T. Kubota T, et al. Sci Rep. 2016 Oct 5;6:34707. doi: 10.1038/srep34707. Sci Rep. 2016. PMID: 27703271 Free PMC article.
15-Deoxy-Δ¹²,¹⁴ prostaglandin J₂ reduces the formation of atherosclerotic lesions in apolipoprotein E knockout mice.
Seno T, Hamaguchi M, Ashihara E, Kohno M, Ishino H, Yamamoto A, Kadoya M, Nakamura K, Murakami K, Matoba S, Maekawa T, Kawahito Y. Seno T, et al. PLoS One. 2011;6(10):e25541. doi: 10.1371/journal.pone.0025541. Epub 2011 Oct 7. PLoS One. 2011. PMID: 22003398 Free PMC article.
Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism.
Higuchi A, Ohashi K, Shibata R, Sono-Romanelli S, Walsh K, Ouchi N. Higuchi A, et al. Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):46-53. doi: 10.1161/ATVBAHA.109.198465. Epub 2009 Nov 12. Arterioscler Thromb Vasc Biol. 2010. PMID: 19910632 Free PMC article.

Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats - PubMed (original) (raw)